Fig 1. PI3K/AKT/mTOR signaling pathway showing interacting activation and regulatory feedback loops. Adapted from Hoeffer and Klann. 35 Mammalian target of rapamycin (mTOR) is a serine-threonine ...
The treatment of head and neck squamous cell carcinoma (HNSCC) is set to undergo rapid changes, as molecular targeted therapy continues to make strides. HNSCCs are characterized by substantial ...
The discovery of phosphatidylinositol 3-kinase (PI3K) changed the way we view and understand growth-factor signaling. From early on, it became clear that PI3K plays an important role in many disease ...
New research identifies the class II PI3K-C2b protein, a member of the PI3 family of kinases, as one of the key regulators of blood vessels growth in humans and other mammals. Mutations in these ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Exelixis, Inc. (NASDAQ:EXEL) today announced that it has granted to Merck, known as MSD outside of the United States and Canada, an exclusive worldwide ...
Exelixis to receive $12M upfront payment and be eligible for potential development, regulatory and commercial milestones, plus royalties SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Dec. 21, 2011-- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results